Gamma Knife Market by 2023 to 2033: Top Challenges and Opportunities
The global gamma knife market is on a
significant growth trajectory, with market size projections reaching USD 702.5
million by 2033, up from USD 337.7 million in 2023. This robust growth reflects
a compound annual growth rate (CAGR) of 7.6% from 2023 to 2033, driven by
expanding applications, favorable reimbursement policies, and growth in
emerging healthcare markets.
Key Market
Drivers and Trends:
The rising
adoption of gamma knife technology is attributed to several key trends:
- Favorable
Reimbursement Policies: In various regions, improved
reimbursement policies are making gamma knife treatment more affordable
and accessible. This trend is enhancing patient access to gamma knife
technology and spurring wider adoption across the globe.
- Expanding
Applications: Originally employed
primarily for brain tumor treatment, gamma knife technology is now being
utilized for a broader range of neurological conditions, including
arteriovenous malformations (AVMs), trigeminal neuralgia, and epilepsy.
This expanded use case is anticipated to further drive market growth over
the coming decade.
- Emerging
Market Opportunities: Emerging economies,
especially in Asia and Latin America, are experiencing substantial
investments in healthcare infrastructure. This development opens up new
growth opportunities for gamma knife technology providers to expand their
footprint and improve treatment accessibility in these regions.
- Collaborative
Efforts with Healthcare Institutions:
Manufacturers are increasingly forming partnerships with healthcare
providers to promote gamma knife technology, offer training for medical
professionals, and increase overall accessibility. These collaborations
are crucial in strengthening the presence of gamma knife solutions within
healthcare systems worldwide.
Market
Outlook:
The gamma knife market’s promising outlook is propelled by innovation and
increasing demand for minimally invasive neurosurgical treatments. With the
continued development of healthcare infrastructure and expanding applications,
gamma knife technology is positioned as a critical tool in advanced
neurological care.
Rising
Demand for Market Data: Our Full Report Offers Deep Insights
and Trend Analysis!
Key
Takeaways from the Market Study:
·
Global gamma knife market was valued at USD 313.8
million by 2022-end.
·
From 2018 to 2022, the market demand expanded at a
CAGR of 7.2%.
·
The market in India is expected to expand at a CAGR of
11.4% through 2033.
·
By disease, the brain metastases segment to account
for a share of 69.2% in 2033.
·
From 2023 to 2033, gamma knife market is expected to
flourish at a CAGR of 7.6%.
·
By 2033, the market value of gamma knife is expected
to reach USD 702.5 million.
Gamma knife can complement regenerative medicine and
stem cell therapies by providing a precise means of targeting specific areas in
the brain for treatment, remarks an FMI analyst.
Competitive Landscape:
Prominent players
in the gamma knife market are Elekta, Varian
Medical Systems, Huiheng Medical, Inc., Akesis, Inc., MASEP Medical Science
Technology Development (Shenzhen) Co., Ltd., American Radiosurgery Inc.,
Panacea Medical Technologies Pvt. Ltd., Nordion (Canada) Inc., Accuray
Incorporated, and Hitachi, Ltd., among others.
Recent Developments:
·
In 2023,
Varian announced the launch of its new Varian gamma knife icon system. The
system features a more compact design, improved image guidance, and a faster
treatment delivery system.
·
In 2022, Akesis announced
the launch of its new Akesis Galaxy SRS system. The system is the first and
only gamma knife system to use a linear accelerator instead of a cobalt 60
source.
Segmentation Analysis of the Gamma Knife Market
By Disease Indication:
·
Brain Metastasis
·
Cancer
·
Arteriovenous Malformation
·
Trigeminal Neuralgia
·
Others
By Anatomy:
·
Head
·
Neck
·
Other Body Parts
By Region:
·
North America
·
Latin America
·
Western Europe
·
Eastern Europe
·
South Asia & Pacific
·
East Asia
The Middle East & Africa
Comments
Post a Comment